Breaking News

Mundipharma Selects BioClinica’s OnPoint CTMS

By Kristin Brooks | January 28, 2014

Customizable solution designed to improve control and efficiency of trials

Mundipharma Research has selected BioClinica’s OnPoint CTMS (Clinical Trial Management System), for various aspects of its clinical trial management activities. OnPoint CTMS is web-based clinical trial management solution designed to improve control and efficiency of clinical trials, providing sponsors the ability to view and manage real-time operational performance.
 
OnPoint’s Office-Smart capabilities will be incorporated with Mundipharma’s Microsoft technologies and will allow users to access, update, and report on clinical trial data from within its existing Microsoft Office and SharePoint, a collaborative portal.
 
“We are very excited about Mundipharma Research’s decision to utilize the OnPoint approach to clinical trial management,” said Peter Benton, president of BioClinica’s eClinical Solutions. “Mundipharma Research is known for being a dynamic organization wholly dedicated to the research and development of highly effective and innovative medications. This requires supporting technologies that empowers users and makes them more productive. OnPoint’s customizable structure and robust reporting capabilities will accomplish this for Mundipharma Research while increasing collaboration and visibility.”

blog comments powered by Disqus
  • Top 25 Pharma and Biopharma Report

    Top 25 Pharma and Biopharma Report

    July 20, 2015
    (Based on 2014 Sales, in $U.S. Millions)

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important